Losartan Potassium Tablet, Film Coated
Product Images NDC 55154-6643
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 55154-6643). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1: Kaplan-meier Estimates Of The Primary Endpoint Of Time To Cardiovascular Death, Nonfatal Stroke, Or Nonfatal Myocardial Infarction In The Groups Treated With Losartan Potassium And Atenolol. (Figure1)
Figure 2: Kaplan-meier Estimates Of The Time To Fatal/nonfatal Stroke In The Groups Treated With Losartan Potassium And Atenolol. (Figure2)
Figure 3: Primary Endpoint Events† Within Demographic Subgroups (Figure 3)
Figure 4: Kaplan-meier Curve For The Primary Composite Endpoint Of Doubling Of Serum Creatinine, End Stage Renal Disease (need For Dialysis Or Transplantation) Or Death. (Figure4)
25mg Bag Label (550314c5 433f 4e48 E063 6394a90a920e 02)
50mg Bag Label (550314c5 433f 4e48 E063 6394a90a920e 01)
100mg Bag Label (550314c5 433f 4e48 E063 6394a90a920e 00)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.